## AMCR: Amcor plc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.55 indicates fundamental undervaluation. Caution: momentum weakening (-5.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($7.98)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Amcor plc (NYSE: AMCR) director sells 6,058 shares to cover taxes**
- Source: Stock Titan | 20251205T060815 | Somewhat-Bearish | Relevance: 100%
- A director at Amcor plc (NYSE: AMCR) sold 6,058 ordinary shares on December 3, 2025, at $8.439 per share. This transaction was disclosed in a Form 4 SEC filing and was conducted to cover the reporting person's tax liability. Following the sale, the director beneficially owns 71,302 shares directly.

**2. Dir Carter Files To Sell 6,058 Of Amcor PLC [AMCR]**
- Source: TradingView | 20251204T032501 | Neutral | Relevance: 100%
- Susan K. Carter, a Director of Amcor PLC (AMCR), filed a Form 144 on December 3, 2025, indicating her intention to sell 6,058 restricted securities. The sale is proposed to occur with Fidelity Brokerage Services around the same date. The Washington Service provides insider trading analysis and data services related to such filings.

**3. Amcor plc (NYSE: AMCR) director reports RSU conversion and 19,907-unit equity award**
- Source: Stock Titan | 20251203T160900 | Neutral | Relevance: 100%
- An Amcor plc director, Lucrece Foufopoulos-De Ridder, converted 14,279 restricted stock units (RSUs) into ordinary shares and received a new grant of 19,907 RSUs. Following the conversion, the director beneficially owns 43,802 ordinary shares directly. The newly granted RSUs are scheduled to vest on December 1, 2026.

**4. Amcor Plc's (NYSE:AMCR) Price In Tune With Earnings**
- Source: 富途牛牛 | 20251205T122222 | Neutral | Relevance: 100%
- Amcor Plc (NYSE:AMCR) has a P/E ratio of 32.9x, significantly higher than the market average of 18x, despite a recent 40% decrease in earnings and a 55% aggregate EPS shrinkage over three years. Analysts project strong future growth of 34% annually for Amcor, compared to the market's 11%, which appears to be supporting its elevated P/E ratio as investors anticipate a recovery. However, the article suggests caution, noting that investors are paying a hefty price for the stock and should be aware of potential warning signs.

**5. Amcor PLC $AMCR Shares Acquired by New York State Common Retirement Fund**
- Source: MarketBeat | 20251205T115419 | Bullish | Relevance: 100%
- The New York State Common Retirement Fund significantly increased its holdings in Amcor PLC (NYSE:AMCR) by 60.9% in the second quarter, now owning 1,038,200 shares valued at $9.54 million. This move is part of broader institutional investor activity, with several other large firms also adding to their stakes in Amcor. The article also provides an overview of recent analyst ratings, financial performance, and dividend information for Amcor.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 22 ($2.26M) |
| Sells | 13 ($0.14M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Blackrock Inc.: 6.7% (-4.6%)
- State Street Corpora: 6.0% (+7.2%)
- Vanguard Group Inc: 4.8% (+1.1%)
- M&G Plc: 4.7% (+26.6%)
- Charles Schwab Inves: 3.5% (+1.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.2% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 7.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 9.3x attractive for 11% earnings growth. Insider buying signal ($2.3M), management confidence. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.2B |
| Beta | 0.68 |
| 52W Range | $7.67 - $10.45 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 9.3 |
| Current P/E | 10.3 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.2% to -3.0% (-5.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.0pp (needs >4.0% for momentum thesis). Underperforming sector by 3.4pp, stock-specific weakness. Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 47. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.03% (CS: 28) | Weak |
| RSI_14 | 46.7 | Neutral |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 0.982x | Below |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 0.922x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $8.30
- **Stop Loss:** $7.98 (3.9% risk)
- **Target:** $8.94 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 3124
- **Position Value:** $25,929.20
- **Portfolio %:** 25.93%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $0.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.18 | $0.19 | +4.9% |
| 2025Q2 | $0.22 | $0.20 | -7.2% |
| 2025Q1 | $0.18 | $0.18 | -1.3% |
| 2024Q4 | $0.16 | $0.16 | +2.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*